CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Erchonia Violet Zerona Z6device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05674292
NCT05674292N/ACompleted
CompareCT.gov

An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring

Erchonia Corporation·interventional·Posted Jan 6, 2023·Updated Sep 13, 2023

In Brief

A clinical study evaluating Erchonia Violet Zerona Z6 for Circumference Reduction. Completed, enrolled 25 participants across 2 sites.

Detailed Summary

The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCircumference Reduction
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 6, 2023
Enrollment StartJul 11, 2022
Primary CompletionMar 28, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.5 years ago

Interventions

Erchonia Violet Zerona Z6device

405nm violet diode low level laser device